Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-1998 | 06-1998 | 03-1998 | 12-1997 | 09-1997 | |
| Sales | 2,573,200 | 2,340,700 | 2,269,100 | 2,258,000 | 2,160,100 |
| Cost of Goods | 667,300 | 626,100 | 602,100 | 685,000 | 587,800 |
| Gross Profit | 1,905,900 | 1,714,600 | 1,667,000 | 1,730,800 | 1,572,300 |
| Operating Expenses | 1,122,400 | 1,072,900 | 930,800 | 1,091,500 | 933,400 |
| Operating Income | 783,800 | 641,800 | 736,300 | 481,500 | 639,700 |
| Interest Expense | 45,700 | 43,100 | 48,600 | 53,700 | 57,300 |
| Other Income | -122,700 | 56,400 | 16,700 | 182,200 | 29,900 |
| Pre-tax Income | 615,400 | 655,100 | 704,400 | 610,000 | 612,300 |
| Income Tax | 97,200 | 163,800 | 176,100 | 152,500 | 155,400 |
| Net Income Continuous | 518,200 | 491,300 | 528,300 | 465,100 | 456,900 |
| Net Income Discontinuous | 0 | 0 | -7,200 | -7,600 | 0 |
| Net Income | $518,200 | $491,300 | $521,100 | $457,500 | $456,900 |
| EPS Basic Total Ops | 0.47 | 0.45 | 0.47 | 0.41 | 0.41 |
| EPS Basic Continuous Ops | 0.47 | 0.45 | 0.48 | 0.42 | 0.41 |
| EPS Basic Discontinuous Ops | N/A | N/A | -0.01 | -0.01 | N/A |
| EPS Diluted Total Ops | 0.46 | 0.44 | 0.46 | 0.40 | 0.41 |
| EPS Diluted Continuous Ops | 0.46 | 0.45 | 0.48 | 0.41 | 0.41 |
| EPS Diluted Discontinuous Ops | N/A | N/A | -0.01 | -0.01 | N/A |
| EBITDA(a) | $906,200 | $759,000 | $855,500 | $591,500 | $764,500 |